✦ LIBER ✦

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease

✍ Scribed by Raza Malik; Michael Chang; Killimangalam Bhaskar; Imad Nasser; Michael Curry; Detlef Schuppan; Valerie Byrnes; Nezam Afdhal

Book ID: 108952165
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 113 KB
Volume: 24
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2008.05731.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonalcoholic Fatty Liver Disease: Predic

Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely Obese

✍ John B. Dixon; Prithi S. Bhathal; Paul E. O'Brien 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Clinical model for distinguishing nonalc

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

✍ Nicole A. Palekar; Rhonda Naus; Steven P. Larson; John Ward; Stephen A. Harrison 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Quality of life in adults with nonalcoho

Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network

✍ Kristin David; Kris V. Kowdley; Aynur Unalp; Fasiha Kanwal; Elizabeth M. Brunt; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 1 views

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States. The association between NAFLD and quality of life (QOL) remains unclear. These data are important to estimate the burden of illness in NAFLD. The aim was to report QOL scores of adults with NAFLD

Risk of nonalcoholic steatohepatitis and

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

✍ Anna Ludovica Fracanzani; Luca Valenti; Elisabetta Bugianesi; Ester Vanni; Anton 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 563 KB

The serum proteome of nonalcoholic fatty

The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis

✍ Miller, Michael H; Walsh, Shaun V; Atrih, Abdel; Huang, Jeffrey T-J; Ferguson, M 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

The serum proteome of nonalcoholic fatty

The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis

✍ Miller, Michael H; Walsh, Shaun V; Atrih, Abdel; Huang, Jeffrey T-J; Ferguson, M 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

## Abstract ## Background and Aim Nonalcoholic fatty liver disease (NAFLD) is a common condition affecting up to 25% of the developed world. It is a progressive disease, leading in some to the development of liver cirrhosis. Currently, accurate diagnosis and staging of this condition is only possi